Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Sunday, February 1, 2026.
MoonLake Immunotherapeutics - Class A Ordinary Shares (NASDAQ:MLTX)
Long-Term Uptrend (+90) - MLTX is in a strong uptrend that is likely to continue. While MLTX is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid MLTX?
MarketClub looks at technical strength and momentum to determine if the timing is right for MLTX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for MLTX
The long-term trend has been UP since Jan 8th, 2026 at 15.555
The intermediate-term trend has been UP since Jan 8th, 2026 at 15.400
The short-term trend has been UP since Jan 28th, 2026 at 16.450
Smart Scan Analysis for MLTX
Based on our trend formula, MLTX is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 16.250 | 16.390 | 15.640 | 15.675 | -0.535 |
| Prev. Close | Volume | Bid | Ask | Time |
| 15.670 | 1079209 | 2026-01-30 15:59:53 |
| 52wk High | 62.75 | 52wk High Date | 2025-09-26 |
| 52wk Low | 5.95 | 52wk Low Date | 2025-09-29 |
| Average Volume | 3,631,827 | Shares Outstanding | 63,705 |
| Assets | 414,335,000M | Liabilities | 125,429,000M |